News archives


OCTOBER - DECEMBER 17

JULY - SEPTEMBER 17

APRIL - JUNE 17

JANUARY - MARCH 17

OCTOBER - DECEMBER 16

JULY - SEPTEMBER 16

APRIL - JUNE 16

JANUARY - MARCH 16

OCTOBER - DECEMBER 15

JULY - SEPTEMBER 15

APRIL - JUNE 15

JANUARY - MARCH 15

OCTOBER - DECEMBER 14

JULY - SEPTEMBER 14

APRIL - JUNE 14

JANUARY - MARCH 14

OCTOBER - DECEMBER 13

JULY - SEPTEMBER 13

APRIL - JUNE 13

JANUARY - MARCH 13

OCTOBER - DECEMBER 12

JULY - SEPTEMBER 12

APRIL - JUNE 12

JANUARY - MARCH 12

OCTOBER - DECEMBER 11

JULY - SEPTEMBER 11

APRIL - JUNE 11

JANUARY - MARCH 11

OCTOBER - DECEMBER 10

JULY - SEPTEMBER 10

APRIL - JUNE 10

JANUARY - MARCH 10

OCTOBER - DECEMBER 09

JULY - SEPTEMBER 09

APRIL - JUNE 09

JANUARY - MARCH 09

OCTOBER - DECEMBER 08

JULY - SEPTEMBER 08

APRIL - JUNE 08

JANUARY - MARCH 08

OCTOBER - DECEMBER 07

JULY - SEPTEMBER 07

APRIL - JUNE 07

JANUARY - MARCH 07

 
  current news   Press   selected story    
     
  10th November 2011  
  IMCB congratulates Executive Director, Professor Wanjin HONG
 
 




Prof Hong Wanjin, Deputy Director (Cancer and Developmental Cell Biology Division), Institute of Molecular & Cell Biology (IMCB) has been appointed the new ED of IMCB with effect from 7 November 2011. Prof Hong’s appointment follows an extensive international search by a Committee led by Sir George Radda, Chairman BMRC.

Prof Hong graduated from Xiamen University (Fujian, China) in 1982 and was one of a few hundred Chinese students chosen for further graduate training in the United States via the China–United States Biochemistry Examination and Application (CUSBEA) programme. He received his Ph.D. from the State University of New York (SUNY Buffalo), and was a postdoctoral fellow there before he joined IMCB as a Principal Investigator in 1989. His research in Singapore has resulted in publication of over 150 research papers with over 6000 citations. Prof Hong received the National Science Award in 1999 for his extraordinarily productive and excellent research in the field of protein transport. Prof Hong was Acting ED IMCB from August 2001 to July 2004, and was also a key member of the IMCB team that was awarded the National Day’s Award 2003 (President’s Certificate of Commendation) for combating and containing SARS. He became Deputy Director (Cancer and Developmental Cell Biology Division) in Aug 2008. Prof Hong is known internationally for his research in protein trafficking in mammalian cells and recently for his work on the Hippo pathway in human cancer. His current and future work will focus on the interface of membrane traffic and Hippo pathway in human diseases, such as cancer. He is currently the Editor-in-Chief for Bioscience Reports (BsR) and a member of the editorial board for several other journals, such as the Journal of Biological Chemistry (JBC), Traffic, and Molecular Membrane Biology (MMB). He is also a Professor at the Department of Biochemistry, National University of Singapore. 

IMCB and Prof Hong express their sincere thanks to Prof Stephen Cohen for his contribution as Acting ED during the past 13 months.

For more information on Wanjin HONG’s laboratory, please click here.